Mangangot, Mark Caleb R.
HRN: 24-14-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
12/01/2023
12/07/2023
IV
14 Mg
Once A Day
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes